Low circulating level of CD133+KDR+cells in patients with systemic sclerosis
- PMID: 21050541
Low circulating level of CD133+KDR+cells in patients with systemic sclerosis
Abstract
Background: Results of previous studies on the level of circulating endothelial progenitor cells (EPCs), which are involved in vascular repair, in scleroderma (SSc) patients have been controversial.
Objectives: To enumerate circulating EPC subsets and to examine their relation with endothelial dysfunction, biochemical markers of endothelial injury and vascular outcome in SSc patients.
Methods: Enumeration of circulating CD34+KDR+ and CD133+ KDR+EPCs was performed by flow cytometry. Endothelium-dependent vasodilation was evaluated by changes in flow-mediated dilation (FMD%) in the brachial artery. Serum level of vascular endothelial growth factor (VEGF) was measured by enzyme linked immunosorbent assay.
Results: SSc patients (n=52) were found to have significantly lower CD133+KDR+EPCs (3.0 vs. 7.0/μl, p<0.001) as well as FMD% (4.8% vs. 7.8%, p<0.001) compared with age and sex-matched controls (n=52). Among patients who had no concomitant cardiovascular risk factors (n=28), CD133+KDR+ EPC level was significantly lower than controls (3.8 vs. 7.3/μl, p=0.001) and correlated modestly with FMD% (r=0.29, p=0.03). Disease duration was the only determining factor identified for circulating CD133+KDR+ EPCs (p=0.03) by logistic regression analysis. Levels of serum VEGF (p=0.92) and KDR expression were not different between patients who had early and intermediate/late disease. Circulating CD34+KDR+ EPCs was not different between SSc patients and controls and did not correlate with any clinical or biochemical parameter.
Conclusions: Lower circulating CD133 +KDR+ EPC subset was found in SSc patients and correlated with impaired endothelium-dependent vasodilation in patients without cardiovascular risk factors suggesting a potential role of deficient EPC recruitment contributing to endothelial dysfunction in this disease.
Similar articles
-
Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.Hypertens Res. 2011 Sep;34(9):1017-22. doi: 10.1038/hr.2011.72. Epub 2011 Jun 9. Hypertens Res. 2011. PMID: 21654754
-
Impaired progenitor cell activity in age-related endothelial dysfunction.J Am Coll Cardiol. 2005 May 3;45(9):1441-8. doi: 10.1016/j.jacc.2004.12.074. J Am Coll Cardiol. 2005. PMID: 15862416
-
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy.J Heart Lung Transplant. 2011 Jan;30(1):70-6. doi: 10.1016/j.healun.2010.07.004. Epub 2010 Sep 15. J Heart Lung Transplant. 2011. PMID: 20817567
-
Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.Z Gastroenterol. 2011 Oct;49(10):1398-406. doi: 10.1055/s-0031-1281752. Epub 2011 Sep 30. Z Gastroenterol. 2011. PMID: 21964893 Review.
-
Endothelial progenitor cells in angiogenesis.Sheng Li Xue Bao. 2005 Feb 25;57(1):1-6. Sheng Li Xue Bao. 2005. PMID: 15719128 Review.
Cited by
-
Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis.Eur J Rheumatol. 2020 Oct;7(Suppl 3):S139-S146. doi: 10.5152/eurjrheum.2019.19158. Epub 2019 Dec 19. Eur J Rheumatol. 2020. PMID: 31922471 Free PMC article. Review.
-
Endothelial Dysfunction in Systemic Sclerosis.Int J Mol Sci. 2023 Sep 21;24(18):14385. doi: 10.3390/ijms241814385. Int J Mol Sci. 2023. PMID: 37762689 Free PMC article. Review.
-
The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis.Front Immunol. 2018 Jun 18;9:1383. doi: 10.3389/fimmu.2018.01383. eCollection 2018. Front Immunol. 2018. PMID: 29967618 Free PMC article. Review.
-
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.Circ Res. 2012 Feb 17;110(4):624-37. doi: 10.1161/CIRCRESAHA.111.243386. Circ Res. 2012. PMID: 22343557 Free PMC article. Review.
-
Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis.Arthritis Res Ther. 2017 Mar 20;19(1):60. doi: 10.1186/s13075-017-1271-7. Arthritis Res Ther. 2017. PMID: 28320472 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials